Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Metastatic and Pretreated Urothelial Cancer
NCT00818350Phase 2Unknown
- Sponsor
- Associazione Giovani Oncologi Campani
- Start
- Jan 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sunitinib in urothelial carcinoma (UC), sponsored by Associazione Giovani Oncologi Campani. Status: unknown.
02
Drugs
sunitinib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00818350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818350.